24 ms·
Powerful cholesterol drug cuts heart attack risk by 31%
- toomuchtodo 7mo agohttps://en.wikipedia.org/wiki/Evolocumab https://en.wikipedia.org/wiki/Evolocumab
- brandonb 7mo agoThis study tested a relatively new drug, PCSK9 inhibitors, which lower LDL cholesterol/ApoB above and beyond what's possible with statins and ezetimibe. The patient population was 3600 people with high-risk diabetes, but not atherosclerosis. So they're at elevated risk compared to the average person. PCSK9 inhibitors are still expensive (about $1,800 per year), with pretty limited insurance coverage. But this will likely change as the evidence builds.
- JoeAltmaier 7mo agoFrom 7% population to 5%. Sounds like a little or a lot, depending how you present the statistic.